5 Best Healthcare Equipment Stocks To Buy For 2014

There�� a bubble in bubbles on Wall Street -- or at least a bubble in blathering about bubbles. For evidence, consider the big, fat bubble that floated on the cover of the November 18th issue of Barron��. You��l also find the bubble meme in recent headlines: �� signs the stock market is in a bubble��(CBS News); ���Definitely a bubble brewing��in stocks: Pro��(CNBC.com) and ��s market bubbles form, investors may want to take cover��(Reuters).

SEE ALSO: 3 Reasons the Stock Market Is Not Overvalued (and One Reason It Might Be)

Here�� the real bubble trouble: When you��e really in one, you rarely hear about it. To those inside, bubbles are almost always invisible.

Top 10 Gas Utility Companies To Invest In Right Now: US Tungsten Corp (USTU)

US Tungsten Corp., formerly Stealth Resources Inc., incorporated on January 10, 2007, is an exploration-stage company. As of October 5, 2012, the Company had begun investigating tungsten opportunities. In September 2013, US Tungsten Corporation completed the registration and acquisition of 64 mineral claims located in Beaverhead, Montana.

On August 21, 2012, the Company acquired an option to acquire a 100% interest in three mineral claims known as the Calvert Property, located in Calvert, Montana (the Property). As of October 5, 2012, the Company had no operating revenues.

Advisors' Opinion:

• [By Peter Graham]

  Small cap mining stocks US Tungsten Corp (OTCMKTS: USTU) and LKA Gold Inc (OTCMKTS: LKAI) along with biotech Entest BioMedical Inc (OTCMKTS: ENTB) have been getting some attention lately in various investment newsletters with at least one of these stocks being the subject of paid promotions while another could soon be the subject of an investor relations campaign. But will any of these small cap stocks be winners for investors or traders? Here is a quick reality check:

5 Best Healthcare Equipment Stocks To Buy For 2014: Conmed Corp (CNMD)

CONMED Corporation (CONMED), incorporated on February 10, 1970, is a medical technology company/ The Company emphasizes on surgical devices and equipment for minimally invasive procedures and monitoring. The Company's products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The Company operates in five segments: CONMED Endoscopic Technologies, CONMED Endosurgery, CONMED Electrosurgery, CONMED Linvatec and CONMED Patient Care.

Arthroscopy

The Company offers a range of devices and products for uses in arthroscopic surgery. The Company's arthroscopy products include powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, metal and bioabsorbable implants as well as related disposable products and fluid management systems. The Company also offers a line of video Endoscopy products suitable for uses in multi-specialty clinical environments beyond orthopedic arthroscopy, including laparoscopy, ear, nose and throat (ENT), gynecology and urology, as well as integrated operating room systems and equipment.

Powered Surgical Instruments

Electric, battery or pneumatic powered surgical instruments are used to perform orthopedic, arthroscopic and other surgical procedures where cutting, drilling or reaming of bone is required. Each power system consists of one or more handpieces and related accessories as well as disposable and limited reusable items (e.g., burs, saw blades, drills and reamers). Powered instruments are categorized as either small bone, large bone or specialty powered instruments. Specialty powered instruments are utilized in procedures such as spinal surgery, neurosurgery, ENT, oral/maxillofacial surgery, and cardiothoracic surgery.

The Company's line of powered instruments is sold principally under the Hall Surgical brand name, for use in large and small bone orthopedic, arthroscopic, oral/maxillofaci! al, podiatric, plastic, ENT, neurological, spinal and cardiothoracic surgeries. Large bone, neurosurgical, spinal and cardiothoracic powered instruments are sold primarily to hospitals while small bone arthroscopic, otolaryngological and oral/maxillofacial powered instruments are sold to hospitals, outpatient facilities and physicians offices.

The Company's powered instruments product line includes the MPower battery system. This orthopedic power system is specifically designed to meet the requirements of orthopedic applications. The MPower battery system allows a facility to purchase a single power system to perform total joint arthroplasty, trauma, arthroscopy, and small bone procedures. The system also provides a multitude of battery technologies to meet the varying needs of hospitals worldwide.

Electrosurgery

The use of electrosurgical units and associated surgical tools is commonplace in the hospital surgical suite, surgery centers, clinics and physician offices. Electrosurgery is routinely used to cut and coagulate tissue and small vessels in open and laparoscopic procedures using energy produced through radio frequency (RF) technology. Electrosurgery can be used in almost all surgical procedures including specialties, such as general, gynecology, orthopedics, cardiology, thoracics, urology, neurology, and dermatology. The Company�� portfolio consist of energy-based products is the Argon Beam Coagulation (ABC) technology. ABC technology combines the use of argon gas and electrosurgical energy to allow the surgeon to produce a surface coagulation which results in less tissue damage.

Patient Care

The Company's patient care product line includes a line of vital signs and cardiac monitoring products, including pulse oximetry equipment and sensors, electrocardiogram (ECG) electrodes and cables, cardiac defibrillation and pacing pads and blood pressure cuffs. The Company also offers a line of suction instruments and tubing for use in the! operatin! g room, as well as a line of intravenous (IV) products for use in the critical care areas of the hospital.

Endosurgery

Endosurgery (also referred to as minimally invasive surgery or laparoscopic surgery) is surgery performed without a incision. The Company's Endosurgical products include the Reflex and PermaClip clip appliers for vessel and duct ligation, Universal S/I (suction/irrigation) and Universal Plus laparoscopic instruments and specialized suction/irrigation electrosurgical instrument systems for use in laparoscopic surgery. The Company also offers cutting and dilating trocars, suction/irrigation accessories, laparoscopic scissors, dissectors and graspers, active electrodes, insufflation needles and linear cutters and staplers for use in laparoscopic surgery. The Company's disposable skin staplers are used to close large skin incisions with surgical staples, thus eliminating the time consuming suturing process. CONMED Endosurgery also offers a uterine manipulator called VCARE for use in increasing the efficiency of laparoscopic hysterectomies and other gynecologic laparoscopic procedures.

Endoscopic Technologies

The Company offers a line of minimally invasive diagnostic and therapeutic products used in conjunction with procedures, which requires flexible endoscopy. The Company's principal customers include gastrointestinal (GI) endoscopists, pulmonologists, and nurses who perform both diagnostic and therapeutic endoscopic procedures in hospitals and outpatient clinics.

The Company's primary focus is to identify, develop, acquire, manufacture and market differentiated medical devices, which improve outcomes in the diagnosis and treatment of gastrointestinal and pulmonary disorders. The Company's diagnostic and therapeutic product offerings for GI and pulmonology include mucosal management devices, forceps, scope management accessories, bronchoscopy devices, dilatation, stricture management devices, hemostasis, biliary devices, and ! polypecto! my.

The Company competes with Smith & Nephew, plc, Arthrex, Inc., Stryker Corporation, ArthroCare Corporation, Johnson & Johnson: DePuy Mitek, Inc., Biomet, Inc., Medtronic, Inc. Midas Rex and Xomed, Synvasive Technology, Inc., Synthes, Inc., MicroAire Surgical Instruments, LLC, Zimmer Holdings, Inc., Covidien Ltd.; Valleylab, Medline Industries, Inc., ERBE Elektromedizin GmbH, Megadyne, Kendall, 3M Company, Ethicon Endo-Surgery, Inc, U.S.Surgical, Boston Scientific Corporation, Wilson-Cook Medical, Inc, Olympus America, Inc. and STERIS Corporation.

Advisors' Opinion:

• [By ovenerio]

  In the medical devices business (83% of FY 13 sales), the company competes with good health care companies such as Johnson & Johnson (JNJ), C.R. Bard (BCR) and ConMed (CNMD).

5 Best Healthcare Equipment Stocks To Buy For 2014: MSCI Inc (MSCI)

MSCI Inc., together with its subsidiaries, provides a suite of performance, risk management, and corporate governance products and services worldwide. The company operates in two segments, Performance and Risk, and Governance. The Performance and Risk segment offers investment decision support tools, including equity indices, real estate indices and benchmarks, portfolio risk and performance analytics, and credit analytics, as well as environmental, social, and governance products. Its products are used in various investment processes, including portfolio construction and rebalancing, performance benchmarking and attribution, risk management and analysis, regulatory and client reporting, index-linked investment product creation, asset allocation, social responsibility assessment, environmental stewardship, investment manager selection, and investment research. The Governance segment provides corporate governance products and services, and specialized financial research and analysis services to institutional investors and corporations. It facilitates the voting of proxies by institutional investors and provides in-depth research and analysis to help inform voting decisions and identify issuer-specific risk; and offers global equity security coverage, and integrated products and services, including proxy voting, policy creation, research, vote recommendations, vote execution, post-vote disclosure, and reporting and analytical tools. This segment also provides class action monitoring and claims filing services to aid institutional investors in the recovery of funds from securities class action settlements. The company offers its products and services under the MSCI, MSCI ESG, Barra, RiskMetrics, ISS, FEA, IPD, and CFRA brands. Its clients include asset owners, institutional and retail asset managers, and financial intermediaries. The company was founded in 1998 and is headquartered in New York, New York.

Advisors' Opinion:

• [By Benjamin Shepherd]

  The iShares MSCI Emerging Markets Index (NYSE: EEM) seems to have halted its slide.� The index bottomed out year-to-date on February 3, when it was down 11.2 percent. Since then, it has gained 1.5 percent, but bargains in the emerging markets still abound.
  
  As I discussed in �� Plan, Not a Panic��two weeks ago, emerging markets are in much better economic shape today than they were even just a few years ago, much less during the currency crisis that peaked in 1998. Foreign exchange reserves are generally much more robust, budget deficits are narrower if they exist at all and, so far at least, the full-blown currency war that many were predicting last year isn�� likely to breakout.
  
  With rationality finally setting in, this is a terrific time to do a little bargain hunting in the emerging markets.
  
  The most obvious play here is the iShares MSCI Emerging Markets Index itself. Covering China (18.8 percent of assets), South Korea (16 percent), Taiwan (12 percent) and Brazil (10.2 percent) with smaller positions spanning Asia and Europe, the fund is most exposed to any shift in sentiment.
  
  The fund is currently trading at just 10.2 times forward one-year earnings, well below its average of about 18 times over the past two decades. On a price-to-sales basis it is even more attractive valued at just 1.03 times; the last time the index was this cheap on a sales basis was early 2009.
  
  So while there are always dangers in trying to call a bottom to any market move, valuations alone are attractive enough to start pulling bargain hunters back in.
  
  A broadly diversified play on an emerging market turnaround, iShares MSCI Emerging Markets Index is a great buy up to 45, which leaves plenty of room to run back to the average.
  
  For those who can tolerate a bit more risk, you can also drill down and make more country-specific bets.
  
  At this point my favorite would be iShares MSCI South Korea Index Fund (NYSE: EWY).
  
  Sout

5 Best Healthcare Equipment Stocks To Buy For 2014: Forward Industries Inc.(FORD)

Forward Industries, Inc., together with its subsidiaries, designs, markets, and distributes carry and protective solutions. The company offers soft-sided carrying cases, bags, clips, hand straps, protective plates, and skins, as well as other accessories for hand held electronic devices, including medical monitoring and diagnostic kits, bar code scanners, GPS and location devices, and cellular telephones. It also designs, markets, and distributes carry and protective solutions for other consumer products, such as laptop computers, MP3 players, firearms, sporting, recreational, and aeronautical products. The company provides its products for used by consumers in protecting, and carrying or transporting portable electronic and other products. Forward Industries, Inc. sells its products to original equipment manufacturers and contract manufacturers in the Asia Pacific, the Americas, and Europe. Forward Industries was founded in 1954 and is based in Santa Monica, California. Advisors' Opinion:

• [By John Udovich]

  Small cap custom carry and protective solutions stock Forward Industries, Inc (NASDAQ: FORD) jumped 22.51% earlier today as an apparent turnaround continues, meaning its worth taking a closer look at a stock that�� in a decidedly niche area plus look at the performance of potential investment benchmarks like the iShares Russell 2000 Index ETF (NYSEARCA: IWM), iShares Russell 2000 Growth Index ETF (NYSEARCA: IWO) and iShares Russell 2000 Value Index ETF (NYSEARCA: IWN).

• [By Chris Woodyard]

  Visitors can see the new Mustang convertible on the observation deck for 54 hours from 8 a.m. to 2 a.m. on April 16 and 17, which just happens to coincide with the New York Auto Show.

  The original 1965 Ford Mustang convertible in Wimbledon White -- the early version known to many as the 1964 1/2. Mustang went on sale on April 17, 1964 and sold more than 418,000 in the first 12 months.  (Photo: Ford)View Fullscreen The sixth-generation, redesigned 2015 Mustang.  (Photo: Ford)View Fullscreen The 1963 Ford Special Falcon: A prototype of the upcoming Mustang on the Falcon chassis before the name was final. At this time it was referred to as the ��pecial Falcon��and had Cougar badges, one of names under consideration.   (Photo: Ford)View Fullscreen Company head Henry Ford II with the 1964 1/2 Mustang Ford at the car's unveiling at the New York World's Fair in Flushing Meadows, N.Y. on April 17, 1964.  (Photo: Ford)View Fullscreen The 1965 Ford Mustang hardtop on display in the Ford Pavilion at the 1964 New York World's Fair where the car was introduced April 17, 1964.  (Photo: Ford)View Fullscreen 1964 Ford Mustang ad from the New York World's Fair.  (Photo: Ford)View Fullscreen Ad photo for the 1965-model Mustang: By June 1964, Mustang has three body styles -- fastback, hardtop and convertible -- with four engine options.  (Photo: Ford)View Fullscreen A 2010 photo of Gail Wise, the first known retail buyer of a Mustang, with her 1965 convertible bought in Chicago. She still owns it and it has been restored.  (Photo: Ford)View Fullscreen Another view of the 1965 Ford Mustang convertible  (Photo: Ford)View Fullscreen 1965 Ford Mustang Shelby GT350: Carroll Shelby helped establish Mustang�� performance credentials by developing the 1965 Mustang Shelby GT350. 
• [By Chris Woodyard]

  For the moment, Cotter says Ford isn't releasing any other pricing information on the next Mustang ��just the base price. To sell off current stocks of Mustang and make way for the new one, he says there are incentives of about $1,000 on the sporty car.

  The redesigned 2015 Ford Mustang is to hit dealerships this fall, a few months after the pony car's 50th birthday.  (Photo: Ford) Fullscreen Ford decided on evolutionary styling on the 2015 Mustang to retain loyalists, hoping the look also is adventuresome enough to draw new buyers.  (Photo: Ford) Fullscreen Dramatic suspension and chassis changes required a wider back end on the 2015 Mustang. Rear wheels are nearly 3 inches further apart and rear fenders are about 1.5 in. wider than on current car.  (Photo: Ford) Fullscreen The 2015 Ford Mustang's headlights are more powerful and the fog lights are relocated.   (Photo: Ford) Fullscreen The design of the 2015 Ford Mustang was done at the huge Mustang studio in Dearborn, Mich., near the automaker's headquarters. That's counter to the trend of designing in California or overseas.  (Photo: Ford) Fullscreen The middle roof pillar -- called the B pillar -- is hidden behind the door glass for a smoother silhouette. The B pillar normally is exposed and sits between the front and rear window glass.   (Photo: Ford) Fullscreen Roof line of the 2015 Mustang is 1.5 in. lower than on its predecessor, to help the car slip through the air easier.  (Photo: Ford) Fullscreen Engineers gave all versions of the 2015 Mustang an independent rear suspension. That's a first, intended to improve ride, handling and steering. It's costlier than the solid rear axle the car has used since l
• [By James R. Healey and Fred Meier] Ford Motor's F-150 continued a sales boom in 2013. Ford's F-series lineup was the best-selling vehicle of any kind in the U.S. for 32nd consecutive year. An F-150 Tremor sport truck model is shown.(Photo: Ford)